{"DataElement":{"publicId":"7556988","version":"1","preferredName":"Person Comorbidity Occurrence Type","preferredDefinition":"A textual description of a person's comorbid condition.","longName":"PRSN_COMORBID_TYP","context":"NIH","contextVersion":"1","DataElementConcept":{"publicId":"2839780","version":"1","preferredName":"Person Comorbidity Occurrence","preferredDefinition":"Person; a human being._The coexistence of two or more disease processes._An instance of something happening, such as an event or incident.","longName":"PERS_COMBD_OCC","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2839778","version":"1","preferredName":"Person Comorbidity","preferredDefinition":"Person; a human being.:The coexistence of two or more disease processes.","longName":"C25190:C16457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63494077-5224-9E3F-E040-BB89AD434641","latestVersionIndicator":"Yes","beginDate":"2009-02-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-19","modifiedBy":"ONEDATA","dateModified":"2009-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63494077-5232-9E3F-E040-BB89AD434641","latestVersionIndicator":"Yes","beginDate":"2009-02-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7555139","version":"1","preferredName":"Comorbid Condition Type","preferredDefinition":"Medical or health condition that is concomitant or concurrent with the primary condition or disease under study._Something distinguishable as an identifiable class based on common qualities.","longName":"COMORBID_TYP","context":"NIH","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"55","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Autoimmune/Immuno compromised","valueDescription":"Autoimmune Disease Or Immunocompromised","ValueMeaning":{"publicId":"7576767","version":"1","preferredName":"Autoimmune Disease Or Immunocompromised","longName":"7576767","preferredDefinition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunocompromised","conceptCode":"C14139","definition":"A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB104AC1-2631-69A4-E053-4EBD850A5148","latestVersionIndicator":"Yes","beginDate":"2021-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB104AC1-264A-69A4-E053-4EBD850A5148","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","deletedIndicator":"No"},{"value":"Immune deficiency/HIV/AIDS","valueDescription":"Immunodeficiency Syndrome Or Human Immunodeficiency Virus Or Acquired Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7576768","version":"1","preferredName":"Immunodeficiency Syndrome Or Human Immunodeficiency Virus Or Acquired Immunodeficiency Syndrome","longName":"7576768","preferredDefinition":"A deficiency of immune response or a disorder characterized by deficient immune response.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB104AC1-265A-69A4-E053-4EBD850A5148","latestVersionIndicator":"Yes","beginDate":"2021-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB104AC1-2673-69A4-E053-4EBD850A5148","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","deletedIndicator":"No"},{"value":"Psychological/psychiatric condition","valueDescription":"Psychological Or Psychiatric Disorder","ValueMeaning":{"publicId":"7576769","version":"1","preferredName":"Psychological Or Psychiatric Disorder","longName":"7576769","preferredDefinition":"Having to do with how the mind works and how thoughts and feelings affect behavior.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psychological","conceptCode":"C94316","definition":"Having to do with how the mind works and how thoughts and feelings affect behavior.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Psychiatric Disorder","conceptCode":"C2893","definition":"A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB104AC1-2681-69A4-E053-4EBD850A5148","latestVersionIndicator":"Yes","beginDate":"2021-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB104AC1-269A-69A4-E053-4EBD850A5148","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","deletedIndicator":"No"},{"value":"Urologic/bladder conditions","valueDescription":"Urinary System Disorder Or Bladder Disorder","ValueMeaning":{"publicId":"7576770","version":"1","preferredName":"Urinary System Disorder Or Bladder Disorder","longName":"7576770","preferredDefinition":"Disorders of any part of the urologic system.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A non-neoplastic or neoplastic disorder affecting the urinary bladder. A representative example of non-neoplastic bladder disorder is bacterial bladder infection. A representative example of neoplastic bladder disorder is bladder carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urinary System Disorder","conceptCode":"C3430","definition":"A non-neoplastic or neoplastic disorder affecting the urinary system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder Disorder","conceptCode":"C2900","definition":"A non-neoplastic or neoplastic disorder affecting the urinary bladder. A representative example of non-neoplastic bladder disorder is bacterial bladder infection. A representative example of neoplastic bladder disorder is bladder carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB104AC1-26A8-69A4-E053-4EBD850A5148","latestVersionIndicator":"Yes","beginDate":"2021-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB104AC1-26C1-69A4-E053-4EBD850A5148","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","deletedIndicator":"No"},{"value":"Cognitive impairment","valueDescription":"Cognitive Impairment","ValueMeaning":{"publicId":"7576146","version":"1","preferredName":"Cognitive Impairment","longName":"7576146","preferredDefinition":"Diminished mental function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cognitive Impairment","conceptCode":"C116921","definition":"Diminished mental function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAE89C27-5B0A-0744-E053-4EBD850A2267","latestVersionIndicator":"Yes","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B23-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Other chronic respiratory disease (e.g.COPD, Emphysema)","valueDescription":"Other Chronic Respiratory System Disease or Disorder","ValueMeaning":{"publicId":"7556895","version":"1","preferredName":"Other Chronic Respiratory System Disease or Disorder","longName":"7556895","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Usually used to describe a condition that is persistent and long standing.: The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Respiratory System","conceptCode":"C12779","definition":"The organs involved in the exchange of carbon dioxide and oxygen including the trachea, bronchi, and lung parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2535A-53CB-4AAB-E053-4EBD850AC05C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5C96-0744-E053-4EBD850A2267","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":"Osteoporosis","ValueMeaning":{"publicId":"2945846","version":"1","preferredName":"Osteoporosis","longName":"2945846","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-1619-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B2D-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Other chronic neurological condition (specify)","valueDescription":"Other Chronic Nervous System Disorder","ValueMeaning":{"publicId":"7556893","version":"1","preferredName":"Other Chronic Nervous System Disorder","longName":"7556893","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Usually used to describe a condition that is persistent and long standing.: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nervous System Disorder","conceptCode":"C26835","definition":"A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2535A-537C-4AAB-E053-4EBD850AC05C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5C82-0744-E053-4EBD850A2267","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Chronic oxygen requirement","valueDescription":"Requirement Chronic Oxygen","ValueMeaning":{"publicId":"7556894","version":"1","preferredName":"Requirement Chronic Oxygen","longName":"7556894","preferredDefinition":"Something that is a necessary condition; something that is obligatory.: Usually used to describe a condition that is persistent and long standing.: A colorless, odorless gas. It is needed for animal and plant life. Oxygen that is breathed in enters the blood from the lungs and travels to the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Oxygen","conceptCode":"C722","definition":"An element with atomic symbol O, atomic number 8, and atomic weight 16.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2535A-53A3-4AAB-E053-4EBD850AC05C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2535A-53BC-4AAB-E053-4EBD850AC05C","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Substance use disorders","valueDescription":"Substance Abuse Disease or Disorder","ValueMeaning":{"publicId":"7556889","version":"1","preferredName":"Substance Abuse Disease or Disorder","longName":"7556889","preferredDefinition":"Maladaptive pattern of drug or alcohol use that may lead to social, occupational, psychological, or physical problems.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Substance Abuse","conceptCode":"C18272","definition":"Maladaptive pattern of drug or alcohol use that may lead to social, occupational, psychological, or physical problems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2535A-52DF-4AAB-E053-4EBD850AC05C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5CAA-0744-E053-4EBD850A2267","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":"Arthritis","ValueMeaning":{"publicId":"3292693","version":"1","preferredName":"Arthritis","longName":"3292693","preferredDefinition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D99F-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B38-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Other hematologic disorders","valueDescription":"Other Hematologic and Lymphocytic Disorder","ValueMeaning":{"publicId":"6156458","version":"1","preferredName":"Other Hematologic and Lymphocytic Disorder","longName":"6156458","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D002-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B4C-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Sickle cell disease","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B57-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B61-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Cerebrovascular accident (eg Stroke, TIA)","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"4733294","version":"1","preferredName":"Cerebrovascular Accident","longName":"4733294","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A141-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B76-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Myocardial disorder (e.g. myocardial infraction)","valueDescription":"Myocardial Disorder","ValueMeaning":{"publicId":"7576148","version":"1","preferredName":"Myocardial Disorder","longName":"7576148","preferredDefinition":"A disorder that affects the muscle tissue of the heart. Representative examples include myocardial infarction, myocarditis, and cardiomyopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Disorder","conceptCode":"C35544","definition":"A disorder that affects the muscle tissue of the heart. Representative examples include myocardial infarction, myocarditis, and cardiomyopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAE89C27-5B83-0744-E053-4EBD850A2267","latestVersionIndicator":"Yes","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5B9C-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Atrial fibrillation","valueDescription":"Atrial Fibrillation","ValueMeaning":{"publicId":"2760267","version":"1","preferredName":"Atrial Fibrillation","longName":"2760267","preferredDefinition":"A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Fibrillation","conceptCode":"C50466","definition":"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3C42-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5BA6-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Other gastrointestinal disorder","valueDescription":"Other Digestive System Disorder","ValueMeaning":{"publicId":"7576149","version":"1","preferredName":"Other Digestive System Disorder","longName":"7576149","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Digestive System Disorder","conceptCode":"C2990","definition":"A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAE89C27-5BB3-0744-E053-4EBD850A2267","latestVersionIndicator":"Yes","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5BCC-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Inflammatory bowel disease","valueDescription":"Inflammatory bowel disease","ValueMeaning":{"publicId":"5417294","version":"1","preferredName":"Inflammatory bowel disease","longName":"5417294","preferredDefinition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Bowel Disease","conceptCode":"C3138","definition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-4268-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5BE0-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Other endocrine disorders","valueDescription":"Other Endocrine System Disorder","ValueMeaning":{"publicId":"7246046","version":"1","preferredName":"Other Endocrine System Disorder","longName":"7246046","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endocrine System Disorder","conceptCode":"C3009","definition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3590C02-BCC4-7FFF-E053-F662850ADCB2","latestVersionIndicator":"Yes","beginDate":"2020-04-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-15","modifiedBy":"ONEDATA","dateModified":"2020-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5BF5-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Hyperthyroidism","valueDescription":"Hyperthyroidism","ValueMeaning":{"publicId":"2946188","version":"1","preferredName":"Hyperthyroidism","longName":"2946188","preferredDefinition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperthyroidism","conceptCode":"C3123","definition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4B32-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5C00-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":"Hypothyroidism","ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5C0B-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Hyperlipidemia","valueDescription":"Hyperlipidemia","ValueMeaning":{"publicId":"2751390","version":"1","preferredName":"Hyperlipidemia","longName":"2751390","preferredDefinition":"An excess of lipids in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0915-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BAE89C27-5C16-0744-E053-4EBD850A2267","beginDate":"2021-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-09","modifiedBy":"ONEDATA","dateModified":"2021-02-09","deletedIndicator":"No"},{"value":"Coronary artery disease","valueDescription":"Coronary Disease","ValueMeaning":{"publicId":"2760269","version":"1","preferredName":"Coronary Disease","longName":"2760269","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3CA7-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D27F95-5801-66D3-E053-4EBD850AFBC8","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Other chronic diseases (specify)","valueDescription":"Other Chronic Disease","ValueMeaning":{"publicId":"7374333","version":"1","preferredName":"Other Chronic Disease","longName":"7374333","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A disease condition that persists over a significant span of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chronic Disease","conceptCode":"C165593","definition":"A disease condition that persists over a significant span of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABA92FEC-1925-28F0-E053-4EBD850A1FB6","latestVersionIndicator":"Yes","beginDate":"2020-07-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-30","modifiedBy":"ONEDATA","dateModified":"2020-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D27F95-5816-66D3-E053-4EBD850AFBC8","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Cancer","valueDescription":"Malignant Neoplasm","ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11B6-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Congestive heart failure","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11C0-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":"Hypertension","ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11CA-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11D5-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Multiple sclerosis","valueDescription":"Multiple Sclerosis","ValueMeaning":{"publicId":"2760060","version":"1","preferredName":"Multiple Sclerosis","longName":"2760060","preferredDefinition":"A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis","conceptCode":"C3243","definition":"A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FE4369C-D09F-4E65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11DF-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Epilepsy","valueDescription":"Seizure Disorder","ValueMeaning":{"publicId":"4827918","version":"1","preferredName":"Seizure Disorder","longName":"4827918","preferredDefinition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure Disorder","conceptCode":"C3020","definition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F1BB-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-11F3-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Asthma","valueDescription":"Asthma","ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-1223-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Chronic liver disease","valueDescription":"Chronic Liver Disease","ValueMeaning":{"publicId":"6660929","version":"1","preferredName":"Chronic Liver Disease","longName":"6660929","preferredDefinition":"Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Liver Disease","conceptCode":"C113609","definition":"Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BD-FFD4-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-1237-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Alzheimer's","valueDescription":"Alzheimer's Disease","ValueMeaning":{"publicId":"3165575","version":"1","preferredName":"Alzheimer's Disease","longName":"3165575","preferredDefinition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease","conceptCode":"C2866","definition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C22C-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-124C-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Dementia","valueDescription":"Dementia","ValueMeaning":{"publicId":"3165569","version":"1","preferredName":"Dementia","longName":"3165569","preferredDefinition":"An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dementia","conceptCode":"C4786","definition":"Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C196-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-1256-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Chronic kidney disease","valueDescription":"Chronic Kidney Disease","ValueMeaning":{"publicId":"2944301","version":"1","preferredName":"Chronic Kidney Disease","longName":"2944301","preferredDefinition":"Gradual and usually permanent loss of kidney function resulting in renal failure. Causes include diabetes, hypertension, and glomerulonephritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease","conceptCode":"C80078","definition":"Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4EFE-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-1260-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity","ValueMeaning":{"publicId":"2945865","version":"1","preferredName":"Obesity","longName":"2945865","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-17B3-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-126A-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Diabetes type II","valueDescription":"Type 2 Diabetes Mellitus","ValueMeaning":{"publicId":"2976115","version":"1","preferredName":"Type 2 Diabetes Mellitus","longName":"2976115","preferredDefinition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 2 Diabetes Mellitus","conceptCode":"C26747","definition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C59A54D-BA0C-5B26-E040-BB89AD432407","latestVersionIndicator":"Yes","beginDate":"2010-01-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-04","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-127F-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Diabetes type I","valueDescription":"Type 1 Diabetes Mellitus","ValueMeaning":{"publicId":"5054471","version":"1","preferredName":"Type 1 Diabetes Mellitus","longName":"5054471","preferredDefinition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 1 Diabetes Mellitus","conceptCode":"C2986","definition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B65-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D2110E-1293-42C3-E053-4EBD850AFA10","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"},{"value":"Alcoholism","valueDescription":"Alcohol Dependence","ValueMeaning":{"publicId":"7555140","version":"1","preferredName":"Alcohol Dependence","longName":"7555140","preferredDefinition":"A chronic disease in which a person craves drinks that contain alcohol and is unable to control his or her drinking.  A person with this disease also needs to drink greater amounts to get the same effect and has withdrawal symptoms after stopping alcohol use. Alcoholism affects physical and mental health, and can cause problems with family, friends, and work.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Dependence","conceptCode":"C93040","definition":"Physical and psychological dependence on alcohol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D0A72F-D312-3AEE-E053-4EBD850ABE76","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9D0A72F-D32B-3AEE-E053-4EBD850ABE76","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ONEDATA","dateModified":"2021-01-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7577014","version":"1","preferredName":"Comorbid Condition Type","preferredDefinition":"Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.:Something distinguishable as an identifiable class based on common qualities.","longName":"C161320:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbid Condition","conceptCode":"C161320","definition":"Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB13FD07-FD22-10B7-E053-4EBD850AD506","latestVersionIndicator":"Yes","beginDate":"2021-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-02-11","modifiedBy":"ONEDATA","dateModified":"2021-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D0A72F-D2FD-3AEE-E053-4EBD850ABE76","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":"2021-1-26 ak Created for SeroNet.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"Comorbidities","type":"NIH COVID","context":"NIH"}],"ReferenceDocuments":[{"name":"Significant underlying medica","type":"Preferred Question Text","description":"Significant underlying medical conditions at the time of COVID-19 testing or diagnosis:","url":null,"context":"NIH"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D2889E-92BC-569E-E053-4EBD850A318B","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"KUMMEROA","dateModified":"2022-03-07","changeDescription":"2021-1-26 ak Created for SeroNet.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}